Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5831750 | International Immunopharmacology | 2016 | 5 Pages |
Abstract
Shiga toxin (STX) is one of the main factors inducing hemorrhagic colitis and hemolytic-uremic syndrome (HUS) in infections with STX-producing Escherichia coli (STEC). Approximately 62% of patients with HUS showed symptoms of encephalopathy in the 2011 Japanese outbreak of STEC infections. At that time, we reported elevated serum concentrations of tumor necrosis factor (TNF)-α in patients with acute encephalopathy during the HUS phase. In the current study, we investigated whether TNF-α augments the effects of STX in glial cell lines and primary glial cells. We found that TNF-α alone or STX in combination with TNF-α activates nuclear factor-κB (NF-κB) signaling and inhibits growth of glial cells. The magnitude of the NF-κB activation and the inhibition of cell growth by the STX and TNF-α combination was greater than that obtained with TNF-α alone or STX alone. Thus, this in vitro study reveals the role of TNF-α in glial cells during STEC infections.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hue Leu, Naotoshi Sugimoto, Masaki Shimizu, Tomoko Toma, Taizo Wada, Kunio Ohta, Akihiro Yachie,